نتایج جستجو برای: a9 everolimus stents drug

تعداد نتایج: 602739  

2013
Shoichi Kuramitsu Masashi Iwabuchi Takenori Domei Kyohei Yamaji Shinichi Shirai Masahiko Goya

We thank Dr Paul D. Williams, Dr Mama A. Mamas, and Dr Douglas G. Fraser for their interest in our article. First, we investigated the stent fracture after Xience V (Abbott Vascular) and Promus (Boston Scientific). As they note, our results, therefore, do not apply to all everolimus-eluting stents. Second, they suggest that double stent strut layer shown in Figure 4 is the consequence of stent ...

2009
R Michael Kirchner J Dawn Abbott

Drug-eluting stents (DES) have had a major impact in interventional cardiology. Compared to bare metal stents, they significantly reduce restenosis and the need for target vessel revascularization. Four DES are available in the US, the first-generation sirolimus-eluting (Cypher((R))) and paclitaxel-eluting (Taxus((R))) stents and later approved second-generation everolimus-eluting (Xience V((R)...

Journal: :Circulation: Cardiovascular Interventions 2012

توان, حامد, رای, علیرضا, سلیمی, ابراهیم, نوروزی, سیروس,

Background: Cardiovascular diseases alone have become the leading cause of death worldwide. One of the treatment methods cardiovascular disease is angioplasty. This study aimed to investigate the clinical results after coronary artery angioplasty, based on the incidence of major cardiovascular events with emphasis on stent types. Methods: In this retrospective cross-sectional study, the preval...

2012
Tullio Palmerini Ajay J. Kirtane Letizia Bacchi Reggiani Hyo-Soo Kim Antoinette De Waha

Background—Some but not all studies have reported reduced rates of stent thrombosis (ST) with everolimus-eluting stents (EES) compared with other drug-eluting stents (DES). All of these studies were insufficiently powered to reliably detect differences in ST. We therefore performed a meta-analysis of randomized controlled trials comparing the risk of 2-year definite ST between EES and other DES...

2017
Satoru Mitomo Toru Naganuma Yusuke Fujino Hiroyoshi Kawamoto Sandeep Basavarajaiah Michael Pitt Wei - Hsian Yin Damras Tresukosol Sunao Nakamura

Chronic total occlusions (CTO) are challenging lesions for percutaneous coronary intervention (PCI); however, innovations in PCI techniques and devices have contributed to increased procedural successes. Although favorable 3-year outcome data have been reported after the implantation of newer generation drug-eluting stents (DES), CTO PCI generally requires long segment of stenting for diffusely...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید